028300.KQ

HLB Co., Ltd. [028300.KQ] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?

028300.KQ Stock Summary

Top 10 Correlated ETFs

028300.KQ

Top 10 Correlated Stocks

028300.KQ

In the News

028300.KQ Financial details

Company Rating

Market Cap

12142.95B

Income

-189.08B

Revenue

42.9B

Book val./share

Cash/share

Dividend

Dividend %

Employees

133

Optionable

Shortable

Yes

Earnings

13 May 2024

P/E

-49.38

Forward P/E

PEG

-4.42

P/S

76.31

P/B

9.24

P/C

P/FCF

-74.13

Quick Ratio

1.55

Current Ratio

1.65

Debt / Equity

LT Debt / Equity

EPS (TTM)

-1.47K

EPS next Y

EPS next Q

EPS this Y

124.66%

EPS next Y

EPS next 5Y

EPS last 5Y

28.9%

Revenue last 5Y

2.23%

Revenue Q/Q

-7.28%

EPS Q/Q

458.18%

SMA20

-3.3%

SMA50

-8.89%

SMA100

-36.03%

Inst Own

Inst Trans

ROA

-13%

ROE

-20%

ROC

-0.15%

Gross Margin

18%

Oper. Margin

-145%

Profit Margin

-146%

Payout

Shs Outstand

Shs Float

Target Price

52W Range

27550.0-129000.0

52W High

-59.77%

52W Low

+88.38%

RSI

54.57

Rel Volume

0.06

Avg Volume

3.8M

Volume

216.92K

Perf Week

4.95%

Perf Month

-4.95%

Perf Quarter

-34.63%

Perf Half Y

-33.63%

Beta

0.481

Volatility

1201.19%, 1612.44%

Prev Close

0.19%

Price

51900

Change

-1.89%

Something similar

Top by Market Cap

Top Correlated ETFs

Top Correlated Stocks

Similar Market Cap

Company Profile

Volume Average 3.8M
Market Capitalization 12142.95B
Employee 133
CEO Mr. Jung-Min Park
Headquarters Ulsan,KR
IPO Date 2008-12-24
Website https://www.hlbkorea.com

HLB Co., Ltd. manufactures pharmaceutical products, and builds ships. It manufactures and sells various types of lifeboats for marine plants, drill ships, and cruise vessels in South Korea. The company offers conventional type lifeboats, free fall type lifeboats, and rescue boats. It also provides marine and yacht engines; hooks; RIB, patrol, fishing, aluminum, and leisure boats; fishery inspection ships; and safety goods, as well as lifeboat and davit inspection and repair services, service engineering training, and spare parts for lifeboats and davits. In addition, the company develops Riboseranib, a targeted anti-cancer agent; and Apilia that is used for the treatment for ovarian cancer. HLB Co., Ltd. was founded in 1975 and is headquartered in Ulsan, South Korea.